6-7398703-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_031480.3(RIOK1):c.443G>T(p.Arg148Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000912 in 1,611,946 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000098 ( 2 hom. )
Consequence
RIOK1
NM_031480.3 missense
NM_031480.3 missense
Scores
4
9
6
Clinical Significance
Conservation
PhyloP100: 7.54
Genes affected
RIOK1 (HGNC:18656): (RIO kinase 1) The protein encoded by this gene competes with pICln for inclusion in the protein arginine methyltransferase 5 complex. This complex targets substrates for dimethylation. The encoded protein is essential for the last steps in the maturation of 40S subunits. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.38787603).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIOK1 | NM_031480.3 | c.443G>T | p.Arg148Leu | missense_variant | 5/17 | ENST00000379834.7 | NP_113668.2 | |
RIOK1 | NM_001348194.2 | c.131G>T | p.Arg44Leu | missense_variant | 5/17 | NP_001335123.1 | ||
RIOK1 | XM_011514933.4 | c.479G>T | p.Arg160Leu | missense_variant | 5/17 | XP_011513235.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIOK1 | ENST00000379834.7 | c.443G>T | p.Arg148Leu | missense_variant | 5/17 | 1 | NM_031480.3 | ENSP00000369162.2 | ||
RIOK1 | ENST00000475351.5 | n.*187G>T | non_coding_transcript_exon_variant | 5/8 | 1 | ENSP00000418263.1 | ||||
RIOK1 | ENST00000475351.5 | n.*187G>T | 3_prime_UTR_variant | 5/8 | 1 | ENSP00000418263.1 | ||||
RIOK1 | ENST00000264874.7 | n.27G>T | non_coding_transcript_exon_variant | 2/13 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152140Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000184 AC: 46AN: 250402Hom.: 0 AF XY: 0.000229 AC XY: 31AN XY: 135310
GnomAD3 exomes
AF:
AC:
46
AN:
250402
Hom.:
AF XY:
AC XY:
31
AN XY:
135310
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000980 AC: 143AN: 1459690Hom.: 2 Cov.: 29 AF XY: 0.000146 AC XY: 106AN XY: 726104
GnomAD4 exome
AF:
AC:
143
AN:
1459690
Hom.:
Cov.:
29
AF XY:
AC XY:
106
AN XY:
726104
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74444
GnomAD4 genome
AF:
AC:
4
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
24
Asia WGS
AF:
AC:
3
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 11, 2024 | The c.443G>T (p.R148L) alteration is located in exon 5 (coding exon 5) of the RIOK1 gene. This alteration results from a G to T substitution at nucleotide position 443, causing the arginine (R) at amino acid position 148 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MutPred
Loss of MoRF binding (P = 0.0064);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at